{
    "eid": "2-s2.0-85161119083",
    "title": "Transient depersonalisation/derealisation syndrome from tramadol",
    "cover-date": "2023-06-06",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Drug interactions",
        "Psychiatry",
        "Toxicology"
    ],
    "authors": [
        "Suthimon Thumtecho",
        "Sorawit Wainipitapong",
        "Polpat Tantakitti"
    ],
    "citedby-count": 0,
    "ref-count": 19,
    "ref-list": [
        "Dissociative disorders in DSM-5",
        "Depersonalization: A new look at a neglected syndrome, by M",
        "CYP2D6 predicts plasma Donepezil concentrations in a cohort of Thai patients with mild to moderate dementia",
        "A method for estimating the probability of adverse drug reactions",
        "Medication-associated depersonalization symptoms: Report of transient depersonalization symptoms induced by Minocycline",
        "Comparative anxiogenic, Neuroendocrine, and other physiologic effects of M-chlorophenylpiperazine given intravenously or orally to healthy volunteers",
        "Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazine",
        "Evidence-based treatment for Depersonalisation-Derealisation disorder (DPRD)",
        "Treatment of depersonalization disorder with Clomipramine",
        "Treatment of depersonalization with serotonin reuptake blockers",
        "Methylphenidate in depersonalization disorder: A case report",
        "Effect of naloxone therapy on depersonalization: A pilot study",
        "Pharmgkb summary: Tramadol pathway",
        "Role of human liver cytochrome P4503A in the metabolism of etoricoxib, a novel Cyclooxygenase-2 selective inhibitor",
        "A case of torsades de pointes induced by severe QT prolongation after an overdose of Eperisone and Triazolam in a patient receiving nifedipine",
        "2321 - Derealization due to Dextroamphetamine: A rare side effect which could cause premature discontinuation of treatment",
        "Depersonalization-derealization syndrome induced by Reboxetine",
        "Enhancing the efficacy of 5-HT uptake inhibitors in the treatment of attention deficit hyperactivity disorder",
        "Cannabis-induced depersonalization-derealization disorder"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60002620",
        "affilname": "Faculty of Medicine, Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
        "affiliation-country": "Thailand"
    },
    "funding": []
}